StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report released on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Price Performance
Shares of ATHX stock opened at $0.00 on Friday. Athersys has a 52-week low of $0.01 and a 52-week high of $1.99. The company has a market cap of $282,981.62, a P/E ratio of 0.00 and a beta of -0.90.
About Athersys
Featured Stories
- Five stocks we like better than Athersys
- Stock Dividend Cuts Happen Are You Ready?
- Buffett Bails on BYD: What It Means for the Future of EV Stocks
- Investing In Preferred Stock vs. Common Stock
- Domino’s vs. Papa John’s: Stock Showdown of Pizza Giants
- Ride Out The Recession With These Dividend Kings
- Williams-Sonoma Makes Stock More Accessible with a Stock Split
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.